Jacob Elebro

725 total citations
28 papers, 492 citations indexed

About

Jacob Elebro is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Jacob Elebro has authored 28 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Jacob Elebro's work include Pancreatic and Hepatic Oncology Research (22 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). Jacob Elebro is often cited by papers focused on Pancreatic and Hepatic Oncology Research (22 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). Jacob Elebro collaborates with scholars based in Sweden, Ireland and Denmark. Jacob Elebro's co-authors include Karin Jirström, Björn Nodin, Margareta Heby, Jakob Eberhard, Roland Andersson, Daniel Ansari, Ann H. Rosendahl, Sebastian Lundgren, Karin Leandersson and Mathias Uhlén and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jacob Elebro

28 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Elebro Sweden 14 345 155 108 107 101 28 492
Marina Kem United States 10 217 0.6× 151 1.0× 64 0.6× 63 0.6× 48 0.5× 18 418
Chuanhua Zhao China 12 278 0.8× 80 0.5× 60 0.6× 74 0.7× 133 1.3× 35 420
Neil Mortensen United Kingdom 13 309 0.9× 184 1.2× 81 0.8× 210 2.0× 52 0.5× 27 552
Aysel Ahadova Germany 13 401 1.2× 120 0.8× 53 0.5× 120 1.1× 247 2.4× 31 629
Eriko Aimono Japan 12 192 0.6× 84 0.5× 54 0.5× 71 0.7× 118 1.2× 40 374
Aaron J. Schueneman United States 7 183 0.5× 158 1.0× 39 0.4× 58 0.5× 89 0.9× 8 377
Charlotta Hedner Sweden 13 236 0.7× 148 1.0× 134 1.2× 141 1.3× 64 0.6× 21 440
Amy Meister United States 7 551 1.6× 125 0.8× 136 1.3× 104 1.0× 62 0.6× 9 674
Ryo Yoriki Japan 5 608 1.8× 80 0.5× 341 3.2× 170 1.6× 57 0.6× 10 717
Enno Dreef Netherlands 11 190 0.6× 143 0.9× 106 1.0× 46 0.4× 112 1.1× 14 489

Countries citing papers authored by Jacob Elebro

Since Specialization
Citations

This map shows the geographic impact of Jacob Elebro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Elebro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Elebro more than expected).

Fields of papers citing papers by Jacob Elebro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Elebro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Elebro. The network helps show where Jacob Elebro may publish in the future.

Co-authorship network of co-authors of Jacob Elebro

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Elebro. A scholar is included among the top collaborators of Jacob Elebro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Elebro. Jacob Elebro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eberhard, Jakob, Jenny Karlsson, Subhayan Chattopadhyay, et al.. (2022). Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer. Molecular Cancer Research. 20(5). 749–761. 5 indexed citations
2.
Nodin, Björn, Jacob Elebro, Jakob Eberhard, et al.. (2021). PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer. The Journal of Pathology Clinical Research. 8(1). 65–77. 4 indexed citations
3.
Lundgren, Sebastian, Jacob Elebro, Margareta Heby, et al.. (2020). Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinoma. International Journal of Cancer. 146(12). 3461–3473. 28 indexed citations
4.
Lundgren, Sebastian, Patrick Micke, Jacob Elebro, et al.. (2020). Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma. Frontiers in Immunology. 11. 558169–558169. 17 indexed citations
5.
Heby, Margareta, Emelie Karnevi, Jacob Elebro, et al.. (2020). Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas. Scientific Reports. 10(1). 10373–10373. 3 indexed citations
6.
Andersson, G., Sebastian Lundgren, Margareta Heby, et al.. (2019). Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma. Biomarker Research. 7(1). 26–26. 1 indexed citations
7.
Lundgren, Sebastian, Jacob Elebro, Margareta Heby, et al.. (2019). Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome. JCO Precision Oncology. 3(3). 1–8. 7 indexed citations
8.
Heby, Margareta, Sebastian Lundgren, Björn Nodin, et al.. (2018). Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma. Journal of Translational Medicine. 16(1). 66–66. 9 indexed citations
9.
Lundgren, Sebastian, Emelie Karnevi, Jacob Elebro, et al.. (2017). The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype. Journal of Translational Medicine. 15(1). 152–152. 26 indexed citations
10.
Karnevi, Emelie, Adil Mardinoğlu, Jacob Elebro, et al.. (2017). Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification. Oncotarget. 9(5). 6188–6200. 13 indexed citations
11.
Lundgren, Sebastian, Jacob Elebro, Margareta Heby, et al.. (2016). The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment. PLoS ONE. 11(6). e0156497–e0156497. 28 indexed citations
12.
Elebro, Jacob, et al.. (2016). Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma. PLoS ONE. 11(4). e0153533–e0153533. 20 indexed citations
13.
Heby, Margareta, Jacob Elebro, Björn Nodin, Karin Jirström, & Jakob Eberhard. (2015). Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma. BMC Clinical Pathology. 15(1). 10–10. 32 indexed citations
14.
Elebro, Jacob & Karin Jirström. (2014). Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma. Diagnostic Pathology. 9(1). 80–80. 20 indexed citations
15.
Elebro, Jacob, Margareta Heby, Alexander Gaber, et al.. (2014). Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma. Journal of Translational Medicine. 12(1). 289–289. 41 indexed citations
16.
Elebro, Jacob, Alexander Gaber, Margareta Heby, et al.. (2014). Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis. PLoS ONE. 9(11). e112728–e112728. 21 indexed citations
17.
Gremel, Gabriela, Julia Bergman, Dijana Djureinovic, et al.. (2013). A systematic analysis of commonly used antibodies in cancer diagnostics. Histopathology. 64(2). 293–305. 13 indexed citations
18.
Ansari, Daniel, et al.. (2011). Single-institution experience with solid pseudopapillary neoplasm of the pancreas. Scandinavian Journal of Gastroenterology. 46(12). 1492–1497. 29 indexed citations
19.
Ansari, Daniel, Ann H. Rosendahl, Jacob Elebro, & Roland Andersson. (2011). Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. British journal of surgery. 98(8). 1041–1055. 87 indexed citations
20.
Klarskov, Louise Laurberg, Steen Ladelund, Susanne Holck, et al.. (2010). Interobserver variability in the evaluation of mismatch repair protein immunostaining. Human Pathology. 41(10). 1387–1396. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Kem Breakdown of academic impact, for papers by Chuanhua Zhao Breakdown of academic impact, for papers by Neil Mortensen Breakdown of academic impact, for papers by Aysel Ahadova Breakdown of academic impact, for papers by Eriko Aimono Breakdown of academic impact, for papers by Aaron J. Schueneman Breakdown of academic impact, for papers by Charlotta Hedner Breakdown of academic impact, for papers by Amy Meister Breakdown of academic impact, for papers by Ryo Yoriki Breakdown of academic impact, for papers by Enno Dreef
Rankless by CCL
2026